Canada markets open in 2 hours 51 minutes

Akari Therapeutics, Plc (AKTX)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.4700-0.3000 (-16.95%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 11.65M
Enterprise Value 7.80M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.07
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.46

Trading Information

Stock Price History

Beta (5Y Monthly) 0.96
52-Week Change 3-52.25%
S&P500 52-Week Change 321.33%
52 Week High 35.5000
52 Week Low 31.0780
50-Day Moving Average 31.7399
200-Day Moving Average 32.9719

Share Statistics

Avg Vol (3 month) 315.21k
Avg Vol (10 day) 328.36k
Shares Outstanding 57.92M
Implied Shares Outstanding 65.06M
Float 89.56B
% Held by Insiders 117.91%
% Held by Institutions 11.61%
Shares Short (Apr 15, 2024) 4575
Short Ratio (Apr 15, 2024) 40.03
Short % of Float (Apr 15, 2024) 40.01%
Short % of Shares Outstanding (Apr 15, 2024) 40.01%
Shares Short (prior month Mar 15, 2024) 45.95k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Aug 17, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-115.51%
Return on Equity (ttm)-1,281.43%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -16.8M
Net Income Avi to Common (ttm)-10.01M
Diluted EPS (ttm)-2.0400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.85M
Total Cash Per Share (mrq)0
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.95
Book Value Per Share (mrq)-0.04

Cash Flow Statement

Operating Cash Flow (ttm)-16.43M
Levered Free Cash Flow (ttm)-16.74M